We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

104 hedge funds and large institutions have $18M invested in Definium Therapeutics in 2023 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 23 increasing their positions, 19 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

388% more call options, than puts

Call options by funds: $6.76M | Put options by funds: $1.39M

133% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 9

48% more capital invested

Capital invested by funds: $12.1M → $18M (+$5.82M)

21% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 19

12% more funds holding

Funds holding: 93 → 104 (+11)

2.48% more ownership

Funds ownership: 9.76% → 12.24% (+2.5%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
104
Holders Change
+11
Holders Change %
+11.83%
% of All Funds
1.52%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
21
Increased
23
Reduced
19
Closed
9
Calls
$6.76M
Puts
$1.39M
Net Calls
+$5.37M
Net Calls Change
+$368K

Top Buyers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
+$1.81M
2
BFM
Boothbay Fund Management
New York
+$442K
3
SC
Scotia Capital
Ontario, Canada
+$367K
4
Jane Street
Jane Street
New York
+$280K
5
Goldman Sachs
Goldman Sachs
New York
+$256K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$390K
2
Citadel Advisors
Citadel Advisors
Florida
-$182K
3
BB
Busey Bank
Illinois
-$151K
4
VF
Virtu Financial
New York
-$89K
5
Group One Trading
Group One Trading
Illinois
-$72.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
PMFA
76
Plante Moran Financial Advisors
Michigan
$132 – – –
ACA
77
American Capital Advisory
Idaho
$121 +$99 +33 New
CAM
78
Chesapeake Asset Management
New York
$120 – – –
IA
79
IFP Advisors
Florida
$110 – – –
AWM
80
Avior Wealth Management
Nebraska
$109 +$18 +6 +25%
AAP
81
Arax Advisory Partners
Colorado
$103 – – –
RF
82
Robbins Farley
New Hampshire
$103 – – –
HWM
83
HighMark Wealth Management
Minnesota
$102 – – –
PP
84
Pacifica Partners
Canada
$70 – – –
VL
85
Vima LLC
Michigan
$70 +$57 +19 New
CP
86
Castleview Partners
Texas
$59 +$48 +16 New
Northwestern Mutual Wealth Management
87
Northwestern Mutual Wealth Management
Wisconsin
$59 +$48 +16 New
SIC
88
SJS Investment Consulting
Ohio
$52 – – –
CB
89
CNB Bank
Pennsylvania
$37 – – –
FWM
90
Focused Wealth Management
New York
$37 – – –
JWM
91
Janiczek Wealth Management
Colorado
$37 – – –
ASN
92
Advisory Services Network
Georgia
$33 +$27 +9 New
SIS
93
Strategic Investment Solutions
Illinois
$22 -$1.12K -372 -98%
BC
94
Belmont Capital
California
$22 – – –
GEA
95
Glen Eagle Advisors
New Jersey
$22 – – –
SPIA
96
Steward Partners Investment Advisory
New York
$22 +$18 +6 New
HCP
97
Hexagon Capital Partners
Arkansas
$15 +$12 +4 New
AF
98
Advisornet Financial
Minnesota
$11 – – –
RIL
99
Rothschild Investment LLC
Illinois
$11 +$9 +3 New
CAS
100
Coppell Advisory Solutions
Texas
$4 +$3 +1 New
1 2 3
4
5

DFTX Hedge Fund Activity: Q4 2023 in Review

104 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q4 2023, worth a combined $18M — up 48% from $12.1M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new DFTX positions and 9 closed out — a net gain of 12 holders — while 23 added to existing stakes and 19 trimmed.

The largest buyer was Ikarian Capital, opening a new position worth an estimated $1.81M. The largest seller was Millennium Management, cutting an estimated $390K.

  • 104 institutional investors held Definium Therapeutics (DFTX) as of Q4 2023, up from 93 in Q3 2023.
  • Funds reported $18M of Definium Therapeutics stock for Q4 2023, up 48% quarter-over-quarter.
  • 21 funds opened new Definium Therapeutics positions in Q4 2023 and 9 closed out, a net change of +12 holders.
  • The largest Definium Therapeutics buyer in Q4 2023 was Ikarian Capital, an estimated $1.81M added.
  • The largest Definium Therapeutics seller in Q4 2023 was Millennium Management, an estimated $390K sold.

Based on aggregated 13F filings for Q4 2023.